Literature DB >> 4992568

BC 105 in the prophylaxis of migraine.

R C Hughes, J B Foster.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1971        PMID： 4992568

Source DB:  PubMed          Journal:  Curr Ther Res Clin Exp        ISSN： 0011-393X


× No keyword cloud information.
  6 in total

1.  IL-1 and IFN-gamma increase vascular permeability.

Authors:  S Martin; K Maruta; V Burkart; S Gillis; H Kolb
Journal:  Immunology       Date:  1988-06       Impact factor: 7.397

2.  The central action of pizotifen.

Authors:  E Przegaliński; L Baran; W Palider; J Siwanowicz
Journal:  Psychopharmacology (Berl)       Date:  1979-04-25       Impact factor: 4.530

3.  Clinical observations with pizotifene (Sandomigran) in the treatment of nonmigrainous depressed women.

Authors:  C M Banki
Journal:  Arch Psychiatr Nervenkr (1970)       Date:  1978-03-07

Review 4.  Pizotifen (BC-105): a review of its pharmacological properties and its therapeutic efficacy in vascular headaches.

Authors:  T M Speight; G S Avery
Journal:  Drugs       Date:  1972       Impact factor: 9.546

Review 5.  Antidepressants for the treatment of chronic pain.

Authors:  Bénédicte Verdu; Isabelle Decosterd; Thierry Buclin; Friedrich Stiefel; Alexandre Berney
Journal:  Drugs       Date:  2008       Impact factor: 9.546

6.  A Comparative Effectiveness Meta-Analysis of Drugs for the Prophylaxis of Migraine Headache.

Authors:  Jeffrey L Jackson; Elizabeth Cogbill; Rafael Santana-Davila; Christina Eldredge; William Collier; Andrew Gradall; Neha Sehgal; Jessica Kuester
Journal:  PLoS One       Date:  2015-07-14       Impact factor: 3.240
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.